STABILITY AND COMPATIBILITY OF FLUOROURACIL AND MANNITOL DURING SIMULATED Y-SITE ADMINISTRATION

被引:1
|
作者
WOLOSCHUK, DMM
WERMELING, JR
PRUEMER, JM
机构
[1] WILLIAM S MIDDLETON MEM VET ADM MED CTR,NEUROL RES LAB,MADISON,WI 53705
[2] UNIV CINCINNATI HOSP,CINCINNATI,OH
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1991年 / 48卷 / 10期
关键词
ADDITIVES; ANTINEOPLASTIC AGENTS; CONCENTRATION; DEXTROSE; DIURETICS; FLUOROURACIL; INCOMPATIBILITIES; INJECTIONS; MANNITOL; SODIUM CHLORIDE; STABILITY; VEHICLES;
D O I
10.1093/ajhp/48.10.2158
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability and compatibility of fluorouracil admixtures with mannitol during simulated Y-site administration was studied. Fluorouracil injection 50 mg/mL was diluted with 5% dextrose injection, 0.9% sodium chloride injection, and 5% dextrose and 0.45% sodium chloride injection to final concentrations of 1 and 2 mg/mL. Combinations of fluorouracil admixtures with 20% mannitol injection were made using equal volumes in glass test tubes; immediately after mixing and at one, two, and four hours, the samples were examined for visual incompatibilities. Duplicate combinations of fluorouracil admixtures with 20% mannitol injection were made using equal volumes in plastic syringes; immediately after mixing with internal standard in glass test tubes and at 2, 4, 8, and 24 hours, samples were removed for chemical analysis. A high-performance liquid chromatographic assay was used to determine fluorouracil concentrations. No evidence of precipitation, color change, or haze was observed. During the 24-hour study, fluorouracil concentrations remained within 6% of initial concentrations for all combinations with mannitol. Fluorouracil 1 and 2 mg/mL in 5% dextrose injection, 0.9% sodium chloride injection, and 5% dextrose and 0.45% sodium chloride injection was chemically stable and visually compatible when combined with 20% mannitol injection during simulated Y-site administration.
引用
下载
收藏
页码:2158 / 2160
页数:3
相关论文
共 50 条
  • [1] Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration
    Sprandel, KA
    Styrczula, DE
    Deyo, K
    Sibley, C
    Rodvold, KA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (01) : 88 - 92
  • [2] Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs
    Bergquist, PA
    Manas, D
    Hunke, WA
    Reed, RA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (13) : 1218 - 1223
  • [3] Stability of levosimendan during simulated y-site administration
    Moore, Wayne S., II
    Cies, Jeffrey J.
    McCulloch, Michael A.
    Davis, Deborah A.
    Mason, Robert W.
    PHARMACOTHERAPY, 2012, 32 (10): : E187 - E188
  • [4] COMPATIBILITY OF FILGRASTIM WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (15): : 1907 - 1913
  • [5] Physical compatibility of colistin with analgesics during simulated Y-site administration
    Dettlaff, Katarzyna
    Kowalska, Aleksandra
    Gostynska, Aleksandra
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (13) : e365 - e371
  • [6] COMPATIBILITY OF AZTREONAM WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (10) : 1086 - 1090
  • [7] Compatibility of doripenem with other drugs during simulated Y-site administration
    Brammer, Matthew K.
    Chan, Pak
    Heatherly, Kathy
    Trusley, Craig
    Kupiec, Thomas C.
    Trissel, Lawrence A.
    Psathas, Petros A.
    Gilmor, Timothy
    Schaufelberger, Daniel
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (13) : 1261 - 1265
  • [8] Compatibility of levofloxacin with 34 medications during simulated Y-site administration
    Saltsman, CL
    Tom, CM
    Mitchell, A
    Fan, JH
    Gailey, RA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (14) : 1458 - 1459
  • [9] COMPATIBILITY OF AMIFOSTINE WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (20) : 2208 - 2212
  • [10] Compatibility of palonosetron with cyclophosphamide and with ifosfamide during simulated Y-site administration
    Xu, QA
    Trissel, LA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (19) : 1998 - 2000